Hospital waste water: health risk for human and environment by cytostatic drug emissions? Part I: Model calculation and chemical monitoring

Meeting Abstract from the 13th Scientific Symposium of the Austrian Pharmacological Society (APHAR). Joint Meeting with the Austrian Society of Toxicology (ASTOX) and the Hungarian Society for Experimental and Clinical Pharmacology (MFT), Vienna, Austria. 2224 November 2007(VLID)90202

BMC Pharmacology / Hospital waste water: health risk for human and environment by cytostatic drug emissions? Part II: Biological monitoring (genotoxicity assays) and risk assessment

Meeting Abstract from the 13th Scientific Symposium of the Austrian Pharmacological Society (APHAR). Joint Meeting with the Austrian Society of Toxicology (ASTOX) and the Hungarian Society for Experimental and Clinical Pharmacology (MFT) Vienna, Austria. 22\u201324 November 200

An integrated assessment of options for rural wastewater management in Austria

M. Starkl, M. Ornetzeder, E. Binner, P. Holubar, M. Pollak, M. Dorninger, F. Mascher, M. Fuerhacker and R. Haberl;Water Science & Technology, 56 (2007): 5, 105-113This paper reports a recently finished, interdisciplinary project on rural wastewater management in Austria. The objective of the project was to study alternative wastewater management options based on separation of the wastewater into its constituent parts, and to compare them with conventional ones. Thereby, a feasibility study of both conventional and alternative options for wastewater management in six model regions was carried out. Life cycle costs and social acceptance were analysed by using a case study-based assessment approach. However, hygienic and environmental risks were evaluated on a more general level. In order to complement the findings, a survey on urine separation system users in the Solar City of Linz was conducted. Based on these assessments and empirical findings, the paper concludes that options using a full separation of all wastewater fractions should be considered with care. Options based on a separation of only grey water and black water or in the liquid/solid phase can offer ecological and financial advantages over conventional options. Further, options combining wastewater management and regional biogas plants were identified as an interesting solution. However, legal constraints restrict this option currently

Bisphenol A emission factors from industrial sources and elimination rates in a sewage treatment plant

Bisphenol A (BPA) is widely used for the production of epoxy resins and polycarbonate plastics and is considered an endocrine disruptor. Special in vitro test systems and animal experiments showed a weak estrogenic activity. Aquatic wildlife especially could be endangered by waste water discharges. To manage possible risks arising from BPA emissions the major fluxes need to be investigated and the sources of the contamination of municipal treatment plants need to be determined. In this study, five major industrial point sources, two different household areas and the influent and effluent of the corresponding treatment plant (WWTP) were monitored simultaneously at a plant serving 120,000 population equivalents. A paper producing plant was the major BPA contributor to the influent load of the wastewater treatment plant. All the other emissions from point sources, including the two household areas, were considerably lower. The minimum elimination rate in the WTTP could be determined at 78% with an average of 89% of the total BPA-load. For a possible pollution-forecast, or for a comparison between different point sources, emission factors based on COD-emissions were calculated for industrial and household point sources at BPA/COD-ratios between 1.4 ×10−6-125×10−6 and 1.3×10−6-6.3×10−6, respectively.</jats:p

Behaviour of bisphenol A (BPA), 4-nonylphenol (4-NP) and 4-nonylphenol ethoxylates (4-NP1EO, 4-NP2EO) in oxidative water treatment processes

Endocrine disrupting chemicals (EDCs) such as natural and synthetic hormones or industrial chemicals can adversely affect the endocrine system at very low concentrations. As such substances can be present in raw water used for drinking-water production, they potentially pose a health risk to humans. In this study laboratory tests were performed to determine removal efficiencies of selected oxidative drinking water treatment processes, namely ozonation (1.4 mg/l O3) and chlorination, using sodium hypochlorite (0.5 mg/l NaClO) and chlorine dioxide (0.4-0.6 mg/l ClO2) under conditions applied in technical plants. 500-300,000 ng/l of bisphenol A (BPA), 4-nonylphenol (4-NP) and 4-nonylphenol-n-ethoxylates (NPnEO) were selected for investigations and measured by HPLC/FLD and HPLC/MS. To investigate possible oxidation by-products, adsorbable organic halogens (AOX) were determined and estrogenic activities were assessed with the help of an estrogen receptor binding assay (YES). Ozonation and chlorination with ClO2 removed both 4-NP and BPA below detection limits, corresponding with AOX and estrogenic activity. Concerning NPnEO ozonation removed NP1EO and NP2EO up to 28% and 30%, respectively, whereas ClO2 showed high removal efficiencies, eliminating &amp;gt;94% and 92%, respectively. NaClO removed 4-NP and BPA below detection limits, but estrogenic activities increased and AOX could be measured. NP1EO and NP2EO were only marginally reduced corresponding to the slight decrease of estrogenic potential.</jats:p